MLchartDataset catalogue

Lonaprisan

Term · Oncology and biomedicine · MLC-T-ONC-014878

An orally bioavailable pentafluoroethyl derivative of a mifepristone-related steroid with antiprogestagenic activity. Lonaprisan is a pure, highly receptor-selective progesterone receptor (PR) antagonist; binding of this agent to PRs inhibits PR activation and the associated proliferative effects. Unlike many other antiprogestins such as mifepristone, this agent does not appear to convert to an agonist in the presence of protein kinase A (PKA) activators and shows high antiprogestagenic activity on both progesterone receptor (PR) isoforms PR-A and PR-B.

Table 1. Record
IdentifierMLC-T-ONC-014878
FieldOncology and biomedicine
Synonymsprogesterone receptor antagonist ZK 230211
ReferencesNational Cancer Institute Thesaurus (CC BY 4.0)
Record as JSON
{
  "id": "MLC-T-ONC-014878",
  "term": "Lonaprisan",
  "field": "Oncology and biomedicine",
  "definition": "An orally bioavailable pentafluoroethyl derivative of a mifepristone-related steroid with antiprogestagenic activity. Lonaprisan is a pure, highly receptor-selective progesterone receptor (PR) antagonist; binding of this agent to PRs inhibits PR activation and the associated proliferative effects. Unlike many other antiprogestins such as mifepristone, this agent does not appear to convert to an agonist in the presence of protein kinase A (PKA) activators and shows high antiprogestagenic activity on both progesterone receptor (PR) isoforms PR-A and PR-B.",
  "synonyms": [
    "progesterone receptor antagonist ZK 230211"
  ],
  "references": [
    "National Cancer Institute Thesaurus"
  ],
  "url": "https://mlchart.com/terminology/oncology/lonaprisan/"
}

Record 10,288 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.